Rituximab in Active Ulcerative Colitis

NCT00261118 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

24

Enrollment

OTHER_GOV

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Rituximab

Sponsor

Royal Liverpool University Hospital

Collaborators

[object Object]
[object Object]